[Federal Register: October 18, 2004 (Volume 69, Number 200)] [Notices] [Page 61357] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr18oc04-35] ----------------------------------------------------------------------- DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Small Molecule Inhibitors of Botulinum Toxin AGENCY: Department of the Army, DoD. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of the invention described in U.S. Provisional Patent Application Serial No. 60/501,243 entitled ``Small Molecule Inhibitors of Botulinum Toxin,'' filed September 8, 2003. The United States government, as represented by the Secretary of the Army, has rights in this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA-Z, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 04-23231 Filed 10-15-04; 8:45 am] BILLING CODE 3710-08-M